(Photo by Paul Hennessy/SOPA Images/LightRocket via Getty Images)

Covid-19 roundup: Pfiz­er, BioN­Tech forge ahead with en­hanced vac­cine; Brii moves on an­ti­body to counter sub­vari­ants

While Pfiz­er and BioN­Tech’s Covid-19 vac­cine has been one of the pri­ma­ry treat­ments so far in the pan­dem­ic, both com­pa­nies are still ad­just­ing and mak­ing …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.